Register Here

Lead Sponsor

Imaging Endpoints

Executive Sponsors

10x Genomics
Adaptive Biotechnologies
Akoya Biosciences
Biodesix®
Fate Therapeutics
GE Healthcare
Genocea
Parexel
Ultivue

Associate Sponsors

Halloran Consulting Group
ImaginAb
Immunai
Iovance
Medidata
Natera
PPD
PRA
Precision for Medicine
Syneos

Showcase Sponsors

Caprion
Cello Health
ClearLight Biotechnologies
HealthMyne
Immuneering
Parse

Supporting Sponsors

ICON
Torreya

Supporting/Educational Partner

Alliance for Regenerative Medicine (ARM)
Cancer Research Institute CRI
Center for Biotechnology (CFB)
JIPO
Society for Immunotherapy of Cancer (SITC)

2021 Media Partner

Gene Therapy Net
MedTech Outlook
Pharma Tech Outlook

Reporting on the Latest Cell & Gene Therapy Progress for Cancer Immunotherapy

The cell and gene therapy field for cancer immunotherapy has seen major success over the past year with landmark approvals and regression in cancers of the blood. However, translating that success into solid tumors has been quite challenging.

Cell & Gene Therapy Day, part of the IO360° three-day event, convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies.

Cell & Gene Therapy Day Delivers Three Key Benefits:

  1. Access to KOLs driving the science
  2. Partnership opportunities with all stakeholders in cell and gene therapy
  3. Presentations on the latest data impacting the science, clinical and business advancements in cell and gene therapy

2022 Keynotes

2022 Featured Speakers

2022 Key Topic Areas: 

  • CRISPR & Clinical Cell Therapy Applications
  • Lessons Learned from CART-PSMA-TGFβRDN
  • Current Landscape of Cell and Gene Therapy
  • Current Clinical Data on ISPC and NK Cells
  • Regulatory Update and Recommendations
  • Integration of Cell Therapy with Single Cell Multi-omics
  • Investment and Collaboration Strategies in Cell and Gene Therapy
  • BCMA Targeted Treatment for Multiple Myeloma
  • Innovations in Cell Therapy Manufacturing
  • Integration of Single Cell Analytics to Understand Why CAR-T Fails & What is Mattering in the TME
  • Novel Targets Beyond T-Cells
  • Synthetic Biology as a Way to Make Better Cell Therapies
  • Advancements in CAR-T for Glioblastoma
 

Cell & Gene Therapy Day is a one day program embedded within the three day IO360˚ program, which includes the Cell & Gene Therapy day. For more information on IO360˚, please click here.

If you are interested in participating in Cell & Gene Therapy Day please contact us at service@tcfllc.org. Thank you.

Sincerely,​

kate-bw-3

Kate Woda
Conference Director

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Strategic Partnerships

elizabeth-bard-bw-2

Elizabeth Bard
Senior Strategic Partnership Manager

Bre Bugbee
Senior Marketing Manager

Adam Kolanko
Strategic Partnership Manager

Meg

Meg Gould
Senior Conference Planner

Efrosini Zambas
Conference Planner